HOUSE DOCKET, NO. 2589 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 2500
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Thomas W. Moakley and Julian Cyr
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to increasing access to epinephrine.
_______________
PETITION OF:
NAME: DISTRICT/ADDRESS: DATE ADDED:
Thomas W. Moakley Barnstable, Dukes and Nantucket 1/16/2025
Samantha Monta√±o 15th Suffolk 4/1/2025
Susannah M. Whipps 2nd Franklin 4/1/2025
Christopher Richard Flanagan 1st Barnstable 4/1/2025
Christopher J. Worrell 5th Suffolk 4/13/2025
Marc T. Lombardo 22nd Middlesex 4/13/2025
Natalie M. Higgins 4th Worcester 4/13/2025
Bridget Plouffe 9th Plymouth 4/14/2025
Marcus S. Vaughn 9th Norfolk 4/14/2025
James C. Arena-DeRosa 8th Middlesex 4/14/2025
Carmine Lawrence Gentile 13th Middlesex 4/16/2025
John F. Keenan Norfolk and Plymouth 4/22/2025
Patrick Joseph Kearney 4th Plymouth 4/24/2025
Patrick M. O'Connor First Plymouth and Norfolk 4/24/2025
Adrian C. Madaro 1st Suffolk 4/30/2025
James B. Eldridge Middlesex and Worcester 5/20/2025
Estela A. Reyes 4th Essex 6/18/2025
Ryan M. Hamilton 15th Essex 6/18/2025
1 of 2

Greg Schwartz 12th Middlesex 7/3/2025
Michelle L. Badger 1st Plymouth 7/10/2025
2 of 2

HOUSE DOCKET, NO. 2589 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 2500
By Representative Moakley of Falmouth and Senator Cyr, a joint petition (accompanied by bill,
House, No. 2500) of Thomas W. Moakley relative to increasing access to epinephrine. Public
Health.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act relative to increasing access to epinephrine.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Chapter 111 of the General Laws is hereby amended by inserting after
2 section 4O the following section:-
3 Section 4P. (a) As used in this section, the following words shall have the following
4 meanings unless the context clearly requires otherwise:
5 "Authorized entity" means any entity or organization at which allergens capable of
6 causing anaphylaxis may be present, including, but not limited to, restaurants, recreation camps,
7 youth sports leagues, amusement parks, colleges, universities, and sports arenas.
8 "Epinephrine autoinjector" means a single-use device used for the automatic injection of
9 a premeasured dose of epinephrine into the human body
10 (b) An authorized entity may acquire and maintain a supply of epinephrine autoinjectors
11 from a wholesaler approved by the department pursuant to this section. All acquired epinephrine
1 of 3

12 autoinjectors shall be stored in a location readily accessible in an emergency and in accordance
13 with the epinephrine autoinjector's instructions for use. An authorized entity shall designate
14 employees or agents who have completed the training required by subsection (d) of this section
15 to be responsible for the storage, maintenance and general oversight of epinephrine autoinjectors
16 acquired under this section.
17 (c) An employee or agent of an authorized entity who has completed the training required
18 by subsection (d) of this section may, on the premises of or in connection with the authorized
19 entity, use epinephrine autoinjectors obtained under this section to provide or administer an
20 epinephrine autoinjector to any individual who the employee or agent believes in good faith is
21 experiencing anaphylaxis for immediate self-administration, regardless of whether the individual
22 has a prescription for an epinephrine autoinjector or has previously been diagnosed with an
23 allergy.
24 (d) An employee, agent, or other individual described in subsection (c) of this section
25 must complete an anaphylaxis training program prior to providing or administering an
26 epinephrine autoinjector made available by an authorized entity. The training must be conducted
27 by a nationally recognized organization experienced in training laypersons in emergency health
28 treatment or by an entity or individual approved by the department of public health. The entity
29 shall submit proof of training to the department and receive approval for the acquisition of
30 epinephrine autoinjectors.
31 (e) An authorized entity that possesses and makes available epinephrine autoinjectors and
32 its trained employees and agents shall not liable for any injuries or related damages that result
33 from the administration or self-administration of an epinephrine autoinjector, the failure to
2 of 3

34 administer an epinephrine autoinjector, or any other act or omission taken pursuant to this
35 section, provided that said immunity does not apply to acts or omissions constituting gross
36 negligence or willful or wanton misconduct.
37 (f) An authorized entity that possesses and makes available epinephrine autoinjectors
38 shall submit to the department of public health, on a form developed by the department, a report
39 of each incident on the authorized entity's premises that involves the distribution or
40 administration of the authorized entity's epinephrine autoinjector. The department of public
41 health shall annually publish a report that summarizes and analyzes all reports submitted to it
42 under this subsection.
43 (g) The department shall promulgate guidance or regulations to carry out this section.
3 of 3

[DELETED: :D/A:DAEITDSA DyBt1o1k4s2n4n1e4l5k4o2x4s4r4e9h4n9k4a8x4e1x4nNh4y4h4rFk4o1k4eMr5s4x6n1x6]
[DELETED: z1x7r1h7]
[DELETED: SsSm"cy"a0(1f]
[DELETED: 2a3w4e5t6a7(8b9e0e1e2h3a4(5m6e7b8t9s0e1(2i3f]
[DELETED: 4a5s6n7(8s9o0a1h2u3(]